Strategies for the Use of Recombinant Human Growth Hormone and Insulin-Like Growth Factor I in Amyotrophic Lateral Sclerosis
- 1 January 1995
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Activity‐Sensitive Signaling by Muscle‐Derived Insulin‐like Growth Factors in the Developing and Regenerating Neuromuscular SystemAnnals of the New York Academy of Sciences, 1993
- Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosisNature, 1993
- Hippocampal and neocortical ubiquitin-immunoreactive inclusions in amyotrophic lateral sclerosis with dementiaNeuroscience Letters, 1992
- Transient IGF-I gene expression during the maturation of functionally related central projection neuronsJournal of Neuroscience, 1991
- Linkage of a Gene Causing Familial Amyotrophic Lateral Sclerosis to Chromosome 21 and Evidence of Genetic-Locus HeterogeneityNew England Journal of Medicine, 1991
- Neurotrophins: structural relatedness and receptor interactionsPhilosophical Transactions Of The Royal Society B-Biological Sciences, 1991
- Nerve sprouting in innervated adult skeletal muscle induced by exposure to elevated levels of insulin-like growth factors.The Journal of cell biology, 1990
- Reduction in insulin receptors in amyotrophic lateral sclerosis correlates with reduced insulin sensitivityNeurology, 1987
- Insulin-like growth factor I/somatomedin C: a potent inducer of oligodendrocyte development.Proceedings of the National Academy of Sciences, 1986
- A unifying hypothesis for the cause of amyotrophic lateral sclerosis, parkinsonism, and alzheimer diseaseAnnals of Neurology, 1981